QQ客服 官方微博 反馈留言

	Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).
	Lin, Feng; Li, Guoxin; Chu, Zhonghua; Hao, Chunyi; Chen, Mingqing; Jiang, Zhiwei; Chen, Huanqiu; Lin, Jianjiang; Li, Dechuan; Hu, Bing
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2015
卷号	33期号:3
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3431145
专题	昆明医科大学
推荐引用方式 GB/T 7714	Lin, Feng,Li, Guoxin,Chu, Zhonghua,et al. Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).[J]. JOURNAL OF CLINICAL ONCOLOGY,2015,33(3).
APA	Lin, Feng.,Li, Guoxin.,Chu, Zhonghua.,Hao, Chunyi.,Chen, Mingqing.,...&Wang, Xishan.(2015).Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)..JOURNAL OF CLINICAL ONCOLOGY,33(3).
MLA	Lin, Feng,et al."Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).".JOURNAL OF CLINICAL ONCOLOGY 33.3(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。